Cephalosporin

From Citizendium
Revision as of 11:01, 26 July 2024 by Suggestion Bot (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.
(CC) Image: David E. Volk
Base structure of all cephalosporins.

Cephalosporins are a class of antibiotic compounds sharing a common base structure, 7-aminocephalosporanic acid (7-ACA), that was derived from the first cephalosporin discovered, cephalosporin C. Penicillins are very similar, although they contain a five-membered ring in place of the six-membered ring present in the cephalosporin. The activity of cephalosporins, penicillins, and some other antibiotics are due to the presence of a beta-lactam, which binds irreversibly, via acylation, to penicillin-binding proteins, thereby inhibiting the peptidogycan layer of bacterial cell wall synthesis. Cephalosporins are often made semisynthetically. Cephalosporins and the very closely relatedcephamycins are collectively referred to as cephems.

Nomenclature

Because the original cephalosporins used the "ceph" form of the spelling and were often trademarked, the International Nonproprietary Names (INN) suggested by the World Health Organization use the "cef" spelling for the generic drug name of all cephalosporins.

First generation cephalosporins


Second generation cephalosporins

In general, second generation cephalosporins have a broader spectrum of activity against Gram-negative bacteria.

Third generation cephalosporins

The third generation has additional activity against Pseudomonas aeruginosa.

Fourth generation cephalosporins

While still active against Enterobacteriaceae and Pseudomonas aeruginosa, this class has much better activity against gram-positive organisms than the third-generation antipseudomonals. The single approved agent is less effective against methicillin-resistant Staphylococcus aureus than the first and second generations. It is not effective against Bacteroides fragilis.